Intuitive Surgical, Inc.
NMS: ISRGLive Quote
📈 ZcoreAI Score
Our AI model analyzes Intuitive Surgical, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get ISRG Z-Score →About Intuitive Surgical, Inc.
Healthcare
Medical Instruments & Supplies
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
📊 Fundamental Analysis
Intuitive Surgical, Inc. demonstrates exceptional profitability, with a profit margin of 28.4%.
The company recently reported 18.8% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is 16.7%, which suggests room for improvement in capital utilization.
At a current price of $450.62, ISRG currently trades near the bottom of its 52-week range (13%), indicating potential value or weakness (Range: $427.84 - $603.88).
💰 Valuation Insight
ISRG trades at a 128.5% premium to the sector average PE of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
✅
Profit Margin
Excellent
🔴
Debt/Equity
Elevated
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$160.05B
Trailing P/E
57.11
Forward P/E
39.43
Beta (5Y)
1.68
52W High
$603.88
52W Low
$427.84
Avg Volume
1.95M
Day High
Day Low